These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 27315207

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The efficacy and performance impact of Fostera PRRS in a Vietnamese commercial pig farm naturally challenged by a highly pathogenic PRRS virus.
    Do DT, Nguyen TT, Nguyen NTH, Nguyen MHP, Le HT, Nguyen NTT, Nguyen NTP, Chae C, Mah CK.
    Trop Anim Health Prod; 2020 Jul; 52(4):1725-1732. PubMed ID: 31898019
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immune response and protective efficacy of intramuscular and intradermal vaccination with porcine reproductive and respiratory syndrome virus 1 (PRRSV-1) modified live vaccine against highly pathogenic PRRSV-2 (HP-PRRSV-2) challenge, either alone or in combination with of PRRSV-1.
    Madapong A, Saeng-Chuto K, Chaikhumwang P, Tantituvanont A, Saardrak K, Pedrazuela Sanz R, Miranda Alvarez J, Nilubol D.
    Vet Microbiol; 2020 May; 244():108655. PubMed ID: 32402335
    [Abstract] [Full Text] [Related]

  • 6. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.
    Madapong A, Saeng-Chuto K, Boonsoongnern A, Tantituvanont A, Nilubol D.
    Sci Rep; 2020 Feb 03; 10(1):1649. PubMed ID: 32015495
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.
    Dwivedi V, Manickam C, Patterson R, Dodson K, Murtaugh M, Torrelles JB, Schlesinger LS, Renukaradhya GJ.
    Vaccine; 2011 May 23; 29(23):4058-66. PubMed ID: 21419162
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.
    Galliher-Beckley A, Li X, Bates JT, Madera R, Waters A, Nietfeld J, Henningson J, He D, Feng W, Chen R, Shi J.
    Vaccine; 2015 Jul 09; 33(30):3518-25. PubMed ID: 26049004
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of a modified-live virus vaccine in pigs experimentally infected with a highly pathogenic porcine reproductive and respiratory syndrome virus type 1 (HP-PRRSV-1).
    Canelli E, Catella A, Borghetti P, Ferrari L, Ogno G, De Angelis E, Bonilauri P, Guazzetti S, Nardini R, Martelli P.
    Vet Microbiol; 2018 Nov 09; 226():89-96. PubMed ID: 30389048
    [Abstract] [Full Text] [Related]

  • 12. Cross-protection of a new type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccine (Fostera PRRS) against heterologous type 1 PRRSV challenge in growing pigs.
    Park C, Choi K, Jeong J, Chae C.
    Vet Microbiol; 2015 May 15; 177(1-2):87-94. PubMed ID: 25769646
    [Abstract] [Full Text] [Related]

  • 13. Safety of PRRSV-2 MLV vaccines administrated via the intramuscular or intradermal route and evaluation of PRRSV transmission upon needle-free and needle delivery.
    Madapong A, Saeng-Chuto K, Tantituvanont A, Nilubol D.
    Sci Rep; 2021 Nov 29; 11(1):23107. PubMed ID: 34845289
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
    Kristensen CS, Kvisgaard LK, Pawlowski M, Holmgaard Carlsen S, Hjulsager CK, Heegaard PMH, Bøtner A, Stadejek T, Haugegaard S, Larsen LE.
    Vaccine; 2018 Jan 04; 36(2):227-236. PubMed ID: 29191738
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Positive immunomodulatory effects of heterologous DNA vaccine- modified live vaccine, prime-boost immunization, against the highly-pathogenic PRRSV infection.
    Sirisereewan C, Nedumpun T, Kesdangsakonwut S, Woonwong Y, Kedkovid R, Arunorat J, Thanawongnuwech R, Suradhat S.
    Vet Immunol Immunopathol; 2017 Jan 04; 183():7-15. PubMed ID: 28063479
    [Abstract] [Full Text] [Related]

  • 18. Gut microbiome associations with outcome following co-infection with porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus type 2 (PCV2) in pigs immunized with a PRRS modified live virus vaccine.
    Constance LA, Thissen JB, Jaing CJ, McLoughlin KS, Rowland RRR, Serão NVL, Cino-Ozuna AG, Niederwerder MC.
    Vet Microbiol; 2021 Mar 04; 254():109018. PubMed ID: 33639341
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of two porcine reproductive and respiratory syndrome (PRRS) modified-live virus (MLV) vaccines against heterologous NADC30-like PRRS virus challenge.
    Chai W, Liu Z, Sun Z, Su L, Zhang C, Huang L.
    Vet Microbiol; 2020 Sep 04; 248():108805. PubMed ID: 32828938
    [Abstract] [Full Text] [Related]

  • 20. Effect of vaccination route (intradermal vs. intramuscular) against porcine reproductive and respiratory syndrome using a modified live vaccine on systemic and mucosal immune response and virus transmission in pigs.
    Renson P, Mahé S, Andraud M, Le Dimna M, Paboeuf F, Rose N, Bourry O.
    BMC Vet Res; 2024 Jan 03; 20(1):5. PubMed ID: 38172908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.